EE03384B1 - Melatoniini kasutamine ravimi tootmiseks - Google Patents

Melatoniini kasutamine ravimi tootmiseks

Info

Publication number
EE03384B1
EE03384B1 EE9700166A EE9700166A EE03384B1 EE 03384 B1 EE03384 B1 EE 03384B1 EE 9700166 A EE9700166 A EE 9700166A EE 9700166 A EE9700166 A EE 9700166A EE 03384 B1 EE03384 B1 EE 03384B1
Authority
EE
Estonia
Prior art keywords
melatonin
medicament
manufacture
Prior art date
Application number
EE9700166A
Other languages
English (en)
Other versions
EE9700166A (et
Inventor
Zisapel Nava
Original Assignee
Neurim Pharmaceuticals (1991) Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/381,535 external-priority patent/US6469044B1/en
Application filed by Neurim Pharmaceuticals (1991) Ltd. filed Critical Neurim Pharmaceuticals (1991) Ltd.
Publication of EE9700166A publication Critical patent/EE9700166A/et
Publication of EE03384B1 publication Critical patent/EE03384B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EE9700166A 1995-02-01 1996-01-29 Melatoniini kasutamine ravimi tootmiseks EE03384B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/381,535 US6469044B1 (en) 1995-02-01 1995-02-01 Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
EP95303853A EP0724878B1 (en) 1995-02-01 1995-06-06 Use of melatonin for treating patients suffering from drug dependencies
PCT/IB1996/000082 WO1996023496A1 (en) 1995-02-01 1996-01-29 Use of melatonin for treating patients suffering from drug addiction

Publications (2)

Publication Number Publication Date
EE9700166A EE9700166A (et) 1998-02-16
EE03384B1 true EE03384B1 (et) 2001-04-16

Family

ID=26140195

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700166A EE03384B1 (et) 1995-02-01 1996-01-29 Melatoniini kasutamine ravimi tootmiseks

Country Status (22)

Country Link
JP (1) JP4516159B2 (et)
CN (1) CN1083263C (et)
AT (1) AT408188B (et)
AU (1) AU695366B2 (et)
BG (1) BG62876B1 (et)
BR (1) BR9607169A (et)
CZ (1) CZ291349B6 (et)
DK (1) DK176081B1 (et)
EE (1) EE03384B1 (et)
FI (1) FI119586B (et)
IS (1) IS1980B (et)
LU (1) LU90118B1 (et)
LV (1) LV11940B (et)
MD (1) MD1716C2 (et)
NO (1) NO312814B1 (et)
NZ (1) NZ298878A (et)
PL (1) PL183148B1 (et)
SI (1) SI9620022A (et)
SK (1) SK284521B6 (et)
TR (1) TR199700723T1 (et)
TW (1) TW483757B (et)
WO (1) WO1996023496A1 (et)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE200200379A (et) 2000-01-05 2003-10-15 Neurim Pharmaceuticals (1991) Ltd. Meetod ja preparaat antihüpertensiivsete ainete suhtes resistentsuse ja sellega seotud haigusseisundite raviks
IL149377A (en) * 2002-04-28 2012-10-31 Neurim Pharma 1991 Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
KR102411809B1 (ko) 2012-01-26 2022-06-22 반다 파마슈티칼즈, 인코퍼레이티드. 일주기 리듬 장애의 치료
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
EP3767297A1 (en) 2012-12-18 2021-01-20 Vanda Pharmaceuticals Inc. Method of determining tau and thereby determining whether a patient has a free-running circadian rhythm
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
ES2828034T3 (es) * 2016-10-31 2021-05-25 Neurim Pharma 1991 Minicomprimidos de melatonina y método de fabricación de los mismos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2134789T3 (es) * 1991-05-09 1999-10-16 Neurim Pharma 1991 Composiciones que contienen melatonina.
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico

Also Published As

Publication number Publication date
PL183148B1 (pl) 2002-05-31
FI973185A0 (fi) 1997-07-31
DK176081B1 (da) 2006-04-18
JP4516159B2 (ja) 2010-08-04
CZ240597A3 (cs) 1998-01-14
IS1980B (is) 2005-01-14
FI973185A (fi) 1997-09-30
MD970254A (en) 1999-05-31
NO973531L (no) 1997-09-30
NZ298878A (en) 1999-05-28
MX9705856A (es) 1998-07-31
CN1172431A (zh) 1998-02-04
AU695366B2 (en) 1998-08-13
SI9620022A (sl) 1998-10-31
AU4457496A (en) 1996-08-21
TR199700723T1 (xx) 1998-02-21
SK284521B6 (sk) 2005-05-05
BG62876B1 (bg) 2000-10-31
MD1716B2 (en) 2001-08-31
CN1083263C (zh) 2002-04-24
NO973531D0 (no) 1997-07-31
TW483757B (en) 2002-04-21
ATA901396A (de) 2001-02-15
DK89697A (da) 1997-07-30
SK103097A3 (en) 1998-01-14
EE9700166A (et) 1998-02-16
CZ291349B6 (cs) 2003-02-12
FI119586B (fi) 2009-01-15
MD1716C2 (ro) 2002-02-28
JPH10513177A (ja) 1998-12-15
BG101803A (en) 1998-04-30
NO312814B1 (no) 2002-07-08
WO1996023496A1 (en) 1996-08-08
PL321630A1 (en) 1997-12-08
LU90118B1 (fr) 1997-11-13
LV11940A (lv) 1998-01-20
IS4532A (is) 1997-07-25
LV11940B (en) 1998-05-20
AT408188B (de) 2001-09-25
BR9607169A (pt) 1997-11-11

Similar Documents

Publication Publication Date Title
FI971279A (fi) Lääkkeitä
NO20040145L (no) Anvendelse av benzensulfonamidderivater for fremstilling av et medikament
ATE192157T1 (de) Therapeutisch verwendbare spiro-azabicyclische verbindungen
IS4662A (is) Innúðatæki
CY2013020I1 (el) Η χρηση μιας ενωσης ινγκενανης για την κατασκευη ενος φαρμακου για την θεραπεια του καρκινου
DK0769017T3 (da) Terapeutiske forbindelser
ATE213142T1 (de) Nasaler dilatator
DE69624072D1 (de) Wegwerfschutzmaske
DE69510024D1 (de) Spritze
IS4698A (is) Innúðatæki
NO306235B1 (no) Anvendelse av et legemiddel for behandling av artritt
DK0830166T3 (da) Inhalationsapparat
PT777457E (pt) A utilizacao de triacetato de glicerilo para o tratamento de onicomicoses
NO975660D0 (no) Anvendelse av benzimidazoler for fremstilling av et medikament for behandling av levkemi
EE03384B1 (et) Melatoniini kasutamine ravimi tootmiseks
EE9700168A (et) Teraapias kasutatavad bitsüklilised isotiokarbamiidi derivaadid
NO993627D0 (no) Anvendelse av en forbindelse for fremstilling av et legemiddel
DK0866699T3 (da) Anvendelse af cholinesteraseinhibitorer til fremstilling af et medikament til behandling af xerostomi
DE59610423D1 (de) Partikulare arzneiform
NO965448D0 (no) Farmasöytiske forbindelser
LV11966A (lv) Pretiekaisumu lidzeklis arigai lietosanai
NO962385D0 (no) Terapeutiske amider
KR970003938U (ko) 환자 보조용 헬멧
KR970020845U (ko) 근골격계질환 치료보조용 테이프
ATE239508T1 (de) Partikulare arzneiform

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

MM4A Lapsed by not paying the annual fees

Effective date: 20070129